Organization
Step Pharma
2 clinical trials
Clinical trial
An Open-Label, Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of the CTPS1 Inhibitor STP938 in Adult Subjects With Advanced Solid Tumors, With a Safety Expansion in Advanced CTPS2 Null Ovarian CancerStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Clinical trial
An Open-Label, First in Human, Phase 1/2 to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of the CTPS1 Inhibitor STP938 In Adult Subjects With Relapsed/Refractory B-Cell and T-Cell LymphomasStatus: Recruiting, Estimated PCD: 2025-12-01